Theralase Technologies Inc. (CVE:TLT - Get Free Report)'s stock price shot up 21.1% during mid-day trading on Monday . The company traded as high as C$0.23 and last traded at C$0.23. 222,201 shares were traded during trading, an increase of 98% from the average session volume of 112,319 shares. The stock had previously closed at C$0.19.
Theralase Technologies Stock Up 100.0 %
The company has a market cap of C$93.31 million, a price-to-earnings ratio of -19.00 and a beta of 1.36. The company has a debt-to-equity ratio of 20.58, a current ratio of 1.21 and a quick ratio of 3.40. The firm has a 50-day moving average price of C$0.18 and a 200 day moving average price of C$0.18.
Theralase Technologies (CVE:TLT - Get Free Report) last issued its quarterly earnings data on Monday, August 12th. The company reported C($0.01) EPS for the quarter. The business had revenue of C$0.10 million during the quarter. Sell-side analysts predict that Theralase Technologies Inc. will post -0.05 EPS for the current year.
About Theralase Technologies
(
Get Free Report)
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
See Also
Before you consider Theralase Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theralase Technologies wasn't on the list.
While Theralase Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
